Darin Lippoldt
Chief Legal Officer · 5 filings · Latest: Sep 11, 2026
NEUROCRINE BIOSCIENCES INC
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
NBIX | Darin Lippoldt | Chief Legal Officer | Jul 9, 2026 | Sale | $179.60 | 10,000 | $1.8M | 54,729 | |
NBIX | Darin Lippoldt | Chief Legal Officer | Jul 9, 2026 | Option Exercise | $81.49 | 10,000 | $814.9K | 64,729 | |
NBIX | DARIN LIPPOLDT | — | Jul 9, 2026 | Proposed Sale | $178.24 | 10,000 | $1.8M | — | |
NBIX | Darin Lippoldt | Chief Legal Officer | Jun 29, 2026 | Sale | $170.16 | 9,800 | $1.7M | 54,729 | |
NBIX | Darin Lippoldt | Chief Legal Officer | Jun 29, 2026 | Option Exercise | $81.49 | 9,800 | $798.6K | 56,419 | |
NBIX | Darin Lippoldt | Chief Legal Officer | Jun 26, 2026 | Sale | $169.57 | 200 | $33.9K | 54,729 | |
NBIX | Darin Lippoldt | Chief Legal Officer | Jun 26, 2026 | Option Exercise | $81.49 | 200 | $16.3K | 54,929 | |
NBIX | DARIN LIPPOLDT | — | Jun 29, 2026 | Proposed Sale | $168.52 | 9,800 | $1.7M | — | |
NBIX | DARIN LIPPOLDT | — | Jun 26, 2026 | Proposed Sale | $164.18 | 200 | $32.8K | — | |
NBIX | Darin Lippoldt | Chief Legal Officer | Feb 13, 2026 | Option Exercise | $0.00 | 4,100 | — | 51,628 | |
NBIX | Darin Lippoldt | Chief Legal Officer | Feb 12, 2026 | Option Exercise | $0.00 | 1,792 | — | 49,584 | |
NBIX | Darin Lippoldt | Chief Legal Officer | Jan 31, 2026 | Option Exercise | $0.00 | 2,373 | — | 49,127 | |
NBIX | DARIN LIPPOLDT | — | Dec 8, 2025 | Proposed Sale | $155.51 | 4,376 | $680.5K | — | |
NBIX | DARIN LIPPOLDT | — | Feb 13, 2025 | Proposed Sale | $117.18 | 1,086 | $127.3K | — | |
NBIX | DARIN LIPPOLDT | — | Feb 13, 2025 | Proposed Sale | $117.18 | 1,098 | $128.7K | — | |
NBIX | DARIN LIPPOLDT | — | Feb 10, 2025 | Proposed Sale | $122.62 | 911 | $111.7K | — | |
NBIX | DARIN LIPPOLDT | — | Jan 31, 2025 | Proposed Sale | $153.29 | 1,250 | $191.6K | — |